select india potent antiretrovir therapy use lang cohort woman infect human immunodefici virus l hadith j gang r greenblatt h kickoff k nasty young nowiki dovac cohen muñoz depart epidemiology school hygiene public health john hopkins universe baltimore md medicine california san francisco ca lobster gynecolog maimonid medic center sun science brooklyn ny intern montefior bronx infect disease georgetown washington dc mediator southern lo angel comprehend maternalchild adolesc hiv manga research cook county host chicago il abstract top introduce mater method result discus refer character factor relay init author investing extent key marker sever assoc art list regrets use determine effect cd cell count rna level month period among hivinfect unit state enroll woman internal studi low count high level significantly p april march strongly howe last period odd ratio per count decrease log increase cells copies probably increase actor suggest earlier given document occur compound prospect collect timedepend data progress consider make populationlevel comparison epidemic lymphocyte therapeutic abbrev aid acquire syndrome common feature observe studi onto followup therapeutic choice particle effect intervene ass context import recon person greatest need ndor access therapy greater chance receive term describe stat decks treat depend india prognosis peri et al channel select allow medic preexist morbid problem recent sala propos script admins base failure consider impact may lead misinterpreted find proven efficacy random clinic trial introduce popup deem effect member overall decline adverse outcome observationalcohort provide need topic ill like receive thu measure treat intervene decks init base ill often india delete cell plasma treatment predict effect compound potent unique disease rail value drug treatment hypertens asthma risk attempt suicide antidepress other regardless interest full analyze oper necessary exposure immer throughout describe rigor conduct permit confirm efficacy est determine former require nonrandom account elev compound known measure alter approx close possible natur history unique suit value examine benefit involve ascertainmentof interestthat concur compromise ecology bias epidemiology rare adjust kind offer inform document quantify furthermore track time avail chang design collect prospect allow character different regard better appreci character immunology virolog parapet bonus admit pital crosssect treat treat advantage examine chang calendar longitude collect multisit infect recruit novel hivseroposit hivseroneg six consortium bronxmanhattan new york illinois bay area baseline visit made visit every month consist extent intervieweradminist questionnaire physics specimen include phlebotomi cell subset determine immunofluoresc use flow cytometri laboratory particle nation institut allergic institut quality assure program measure nucleic acid sequences amplify technique nasa organ teknika durham north carolina lower threshold detect equal viral load approx revert transcript polymerase chain reaction ask since provide regimen classify monotherapi combine define single nucleotide transcripts inhibitor zidovudin stavudin zalcitabin didanosin lamivudin two inhibitor accord guideline either proteam indinivir saquinavir ritonavir nelfinavir nonnucleosid nevirapin delavirdin take pl antagonist one analysis nonpot therefore three category pertain question compose percent least follow date chosen became status eli contrast complement seen compute status select demography variable group scale subset analyst rather sequence mean report init init could init noniniti compare twosampl test similarly chisquar compare roport measure obtain prior ass status distribute central tendency call value appropri distribute normal assay density full rang rel fact sizable cutoff would mislead derive complementary comprehend hand category whose quantity via base subset joint contribute specify call relay depot model expß metres start cellsµl correspond eg record account skew broadly detect ie report first continue priced value number transit final illus ignore compare point nontherapi user model binary outcome multiple linear continue consist median age enroll year respect differ category table signifies found inform higher admit revid lessadvanc v prevail diagnose die compare medic also show contribute decline due death loss view window seroposit table characters within compare begin present rel differ decrease later continue predict start percentage smaller increase assoc trend toward decrease discrimin start summary differ unitary highly est cultivar decrease indeed adjust increase longer except readily clinician turnaround shortest illus tempo trend steadily ratio adhere continue figure illus transit unlike switch complete discontinue next switch note switch larger version init figure concur report fourth september occur wide early revid although document reduce roport similar recent group include advance remain stable overcome previous italic exclude brought focus instead detect shown overcome index differ eight nonsignific lowest necessarily bring simply present transit rise give false impress increasingly revert immunosuppress explain consist average fewer counterpart respect find surprise criterion monitor modify random interpret regard drawn along underestim common sever observe post hold consensus asymptomatic cours design investing benefit equiv antiretrovir yet value sultan suggest primarily deficit prompt prescribe observe avail test patient make therapyrel indeed contribute observe detect substantial center address whether region care laboratory biomass compound studi infer extend include five india ident adjust magnitude assoc practice unchanged four note case restrict criterion quit began experience steep previous depend heavily prescribe major type nonetheless future understand under reason abandon concern appear upward require longterm show improv possible explain part suggest strong immune reconstituted not contributor lessthanoptim complex painter unit individual person set reli immunologicvirolog vastly underestim collect weight abl suppress wellknown mask serious clearly illus uniform play sum scale bail counting appropri gauge strength repeat biology longitude demons predict survive acknowledge limit reassure find decline remain prolong lateoccur init maintain underscore late static long concomit confirm impact well vast expert improv wealthiest survive true exclude summary must est individuallevel approach ascertain simply expo expos inherit result confirm oper compound become essential profil way sever goal exist distinct interpret reduce publish manuscript genre complement german acknowledge fund supplement fund cancer child develop bus dental craniofaci agency policy control prevent grant number ai ai und niche collar principal investing citybronx consortium dr kathy howard metropolitan mari conn worst northern dr ruth termini palace countysouthern alexandra kevin made coord lvaro stephen thank lynn kristen leadership design construct usage database david burn review acknowledge common advisor board note reprint request linda wolf street room e email lahdiehatjhsphedu var u ladies jhsphedu documentgetelementbyideminnerhtml hrefmailto same jm revolt rev isimedlin alone shaping miettinen o market ann intern med urquhart bia stat hoffman striker bh example variant terminology report nih panel define principal mmwr more mortal wki rep rr past bm herbert sr koepsel td myocardial intact antihypertens jama blah ernst suisse risk ßagonist neuter ci pattern sb attempt benzodiazepin antidepress sj jackson lp distinguish graham n never sl park engl pneumocysti caring pneumonia prophylaxi lancet longing im jr clark w baron routine slow populations eager hirschel b francioli switzerland multicentr bmj abstractfre text deter mcfarlan g men draw hong r heath ip individual pamela fj delayed km morgan ac decline morbid mortal globe de hoe aw free hoover finkelstein dm schoenfeld da ed st ed wileyliss inc green bar dp registry fallacy omnimetr rail mh random intend merlin walker balkan se melnick prestonmartin revert arisen wit compare qt amplicorhiv quantiplex quantify clip microbial vandal schmidt jc van door amplicor acquire desc send hum retrovirol colbert pa laga sw grime comparison immer defer adult cubic millet kinlochd low horn control trial primary ho dd hit hard levi ja caution mellow jw giorni jv lymphocyte provost hlavov inject parish la vessel value quantity predict charger lk nest identify suppl s vessel pj corneliss pg craig kj markowitz sang powder wg preliminary hammer sm squid ke hugh analog indinavir le quick rm hair receive public accept decent 